子课题3-脊髓髓内肿瘤导致的神经损伤再生的临床研究研究数据

本研究是单中心、随机对照的前瞻性临床研究。按照入组标准将患者随机分为实验组及对照组。对照组常规行脊髓髓内肿瘤切除术，实验组在脊髓髓内肿瘤切除术的基础上术区移植经西妥昔单抗修饰的生物胶原支架。对两组患者分别行术前、术后神经功能状态评价并长期随访，观察实验组治疗方案的临床安全性与初步有效性。This is a single-center, randomized controlled prospective clinical trial. Patients were randomly assigned to the experimental group and the control group according to the inclusion criteria. The control group underwent routine intramedullary spinal cord tumor resection, while the experimental group received intramedullary spinal cord tumor resection combined with transplantation of cetuximab-modified biocollagen scaffolds at the surgical site. Neurological function of patients in both groups was evaluated preoperatively and postoperatively, and long-term follow-up was conducted to assess the clinical safety and preliminary efficacy of the therapeutic regimen in the experimental group.

搜集汇总

背景与挑战

背景概述

该数据集是一个关于脊髓髓内肿瘤导致神经损伤再生的临床研究数据，包含一个单中心随机对照前瞻性研究，涉及6个样本和4个PDF附件。研究重点在于比较常规肿瘤切除与结合西妥昔单抗修饰生物胶原支架移植的治疗方案，旨在评估神经修复的安全性和初步有效性，但无测序或图像数据。